LAURA SCARBROUGH: Open Payments
NPI 1982369997 · HIRAM, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$732 in 29 payments from 12 companies in 2025. Trend: 2023 $1,108 · 2024 $1,585 · 2025 $732
Food & beverage: $732
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 3 | $173 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| ABIOMED | 1 | $73 |
| BridgeBio Pharma, Inc. | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| Novo Nordisk Inc | 3 | $58 |
| Merck Sharp & Dohme LLC | 3 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $36 |
| Amgen Inc. | 2 | $33 |
Products named: AMVUTTRA, FARXIGA, Attruby, Kerendia, Ozempic, LifeVest, VERQUVO, JARDIANCE.
Industry payments across GA — which companies pay providers there.
